11 research outputs found

    S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain

    Full text link
    <div><p>Ca2<sup>+</sup>-binding human S100A1 protein is a type of S100 protein. S100A1 is a significant mediator during inflammation when Ca<sup>2+</sup> binds to its EF-hand motifs. Receptors for advanced glycation end products (RAGE) correspond to 5 domains: the cytoplasmic, transmembrane, C2, C1, and V domains. The V domain of RAGE is one of the most important target proteins for S100A1. It binds to the hydrophobic surface and triggers signaling transduction cascades that induce cell growth, cell proliferation, and tumorigenesis. We used nuclear magnetic resonance (NMR) spectroscopy to characterize the interaction between S100A1 and the RAGE V domain. We found that S100B could interact with S100A1 via NMR <sup>1</sup>H-<sup>15</sup>N HSQC titrations. We used the HADDOCK program to generate the following two binary complexes based on the NMR titration results: S100A1-RAGE V domain and S100A1-S100B. After overlapping these two complex structures, we found that S100B plays a crucial role in blocking the interaction site between RAGE V domain and S100A1. A cell proliferation assay WST-1 also supported our results. This report could potentially be useful for new protein development for cancer treatment.</p></div

    Analysis of the <sup>1</sup>H–<sup>15</sup>N HSQC spectra of S100B in complex with the unlabeled S100A1.

    Full text link
    <p>(A) Overlapped NMR HSQC spectra of <sup>15</sup>N-S100B in black and <sup>15</sup>N labeled S100B complex with unlabeled S100A1 in a 1:1M ratio (red). Residues displaying significant intensity decreases and those with perturbed chemical shifts are framed by boxes (green and blue, respectively).</p> <p>(B) Bar plot showing the changes in the intensity ratio (I/I0) comparing the <sup>15</sup>N S100B and the complex of <sup>15</sup>N S100B with S100A1. The blue line shows the threshold of selected residues that display a notably reduced intensity.</p> <p>(C) Bar plot presenting the changes in chemical shift perturbation comparing free <sup>15</sup>N S100B and the <sup>15</sup>N S100B in complex with Ca<sup>2+</sup>-bound S100A1. The blue line shows the threshold of selected residues that display a notable perturbation.</p> <p>(D) Ribbon (stick) diagram of the S100B in red obtained using the PyMOL program. The residues that show chemical shift perturbations and intensity decreases are shown in blue.</p

    Analysis of the <sup>1</sup> H–<sup>15</sup>N HSQC spectrum of the RAGE V domain with unlabeled S100A1.

    Full text link
    <p>(A) The superimposed <sup>1</sup>H-<sup>15</sup>N HSQC spectra of <sup>15</sup>N V domain in black and <sup>15</sup>N V domain complex with S100A1 in red are in a molar ratio of 1:1. Cross-peaks displaying significantly decreased intensity are shown in green boxes.</p> <p>(B) Bar graph analysis representing the intensity change (I/I<sub>0</sub>) of cross-peaks of <sup>15</sup>N V domain to <sup>15</sup>N V domain complex with S100A1 versus residue numbers of RAGE V domain (24–128). I<sub>0</sub> denotes the initial intensity of <sup>15</sup>N V domain, and I denotes the intensity of <sup>15</sup>N V domain complex with S100A1. The blue line represents the criterion of selected residues that exhibit significantly decreasing cross-peak signals, and the chosen residues are indicated by red bars.</p> <p>(C) Ribbon representing the structure of V domain and residues that exhibit significantly decreasing cross-peak signals are mapped on the structure in blue.</p

    Analysis of the <sup>1</sup>H–<sup>15</sup>N HSQC spectra of S100A1 in complex with the unlabeled RAGE V domain.

    Full text link
    <p>(A) Superimposed <sup>1</sup>H-<sup>15</sup>N HSQC spectra of <sup>15</sup>N S100A1 (in black) and <sup>15</sup>N S100A1 in complex with unlabeled RAGE V domain (red). Cross-peaks display significantly decreased intensity, and those with perturbed chemical shifts are boxed in green and blue, respectively.</p> <p>(B) Bar plot showing the chemical shift variations in cross-peaks for S100A1 and the S100A1-V domain complex. The threshold (blue line) of the chosen residues (red) displays a notable perturbation.</p> <p>(C) Bar graph analysis representing the change in intensities (I/I<sub>0</sub>) of cross-peaks of free <sup>15</sup>N S100A1 to <sup>15</sup>N S100A1 in complex with V domain against residue numbers of S100A1 (1–93). I<sub>0</sub> denotes the initial intensity of free <sup>15</sup>N S100A1, and I denotes the intensity of <sup>15</sup>N S100A1 in complex with V domain. The blue line represents the criterion of selected residues that exhibit a significantly decreasing cross-peak signal, and the chosen residues are displayed in red bars.</p> <p>(D) Ribbon representing the structure of homo-dimer. The monomers of S100A1 homodimer are colored in green and blue.</p> <p>(E) A monomer of S100A1 and residues that exhibit significantly decreasing cross-peak signals are mapped on the structure in magenta.</p

    Analysis of WST-1 assays.

    Full text link
    <p>A. SW-480 cells were treated with 10 nM, 50 nM, or 100 nM S100 A1 (blue); 100 nM S100 A1 + 100 nM S100B (green). Cell proliferation was analyzed using a WST-1 assay. The relative cell counts following treatment with S100A1 are plotted as the fold induction with serum-free media as the corresponding controls (red). The data are expressed as the mean ± SD from 4 independent experiments.</p

    Curve with fluorescence intensity changes versus S100B concentrations obtained at a wavelength of 351 nm.

    Full text link
    <p>K<sub>d</sub> is calculated as 1.9 ±0.1 μM from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190545#pone.0190545.e005" target="_blank">Eq 4</a> [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190545#pone.0190545.ref083" target="_blank">83</a>].</p

    Hypothetical mechanism of the S100A1-RAGE signaling pathway.

    Full text link
    <p>The extracellular V domain of the RAGE protein binds to the S100A1 dimer, facilitating intracellular dimerization of the cytoplasmic domain. This activates a signaling cascade (MAP kinase, NF-κB, and AP-1), leading to downstream cell proliferation or inflammation.</p

    Analysis of the <sup>1</sup>H–<sup>15</sup>N HSQC spectra of S100A1 in complex with the unlabeled S100B.

    Full text link
    <p>(A) Overlapped NMR HSQC spectra of <sup>15</sup>N-S100A1 in black and <sup>15</sup>N S100A1 complex with unlabeled S100B in a 1:1 ratio (red). Residues displaying significant intensity decreases and perturbed chemical shifts are shown by boxes (green and blue, respectively).</p> <p>(B) Bar plot presenting the changes in cross-peak chemical shift of free-form S100A1 and the S100A1-S100B complex. The blue line shows the threshold of selected residues (red) that display a notable perturbation.</p> <p>(C) Bar plot presenting the decrease in the cross-peak intensity ratio (I/I<sub>0</sub>) of S100A1 and the S100A1-S100B complex. The threshold (blue line) of chosen residues indicates a notably reduced intensity. Selected residues are highlighted in red.</p> <p>(D) Ribbon (stick) diagram of S100A1 in green obtained using the PyMOL program. The residues that exhibit chemical shift perturbations and intensity decreases are shown in magenta.</p

    Complex structure of S100A1 and RAGE V domain.

    Full text link
    <p>(A) Ribbon diagram of the S100A1-V domain complex. Two monomers of S100A1 are shown in green and blue; the two RAGE V domains are shown in yellow. Interacting residues are shown in magenta and red.</p> <p>(B) Ribbon diagram of the S100A1-V domain complex showing with different angle.</p
    corecore